Objective To explore the correlations between the expression of natriuretic peptide receptor A and the levels of serum amino terminal brain natriuretic peptide precursor (NT-proBNP) and transforming growth factor (TGF)-β1 and cardiac function in patients with diabetic cardiomyopathy. Methods A total of 120 patients with diabetic cardiomyopathy admitted to the Second Affiliated Hospital of Xi'an Medical College from May 2020 to May 2023 were retrospectively selected as a diabetic cardiomyopathy group, 70 healthy people during the same period were selected as a control group, and 50 diabetic patients receiving treatment during the same period were selected as a diabetic group. In the control group, there were 41 males and 29 females, aged (47.16±6.24) years. In the diabetic group, there were 29 males and 21 females, aged (47.62±6.56) years. In the diabetic cardiomyopathy group, there were 62 males and 58 females, aged (48.08±6.88) years. The baseline data, natriuretic peptide receptor A, NT-proBNP, TGF-β1, soluble growth stimulation expression gene 2 protein (sST2), matrix metalloproteinase-2 (MMP-2), tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), total cholesterol (TC), triacylglycerol (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), left ventricular remodeling index (LVRI), left ventricular posterior wall thickness (LVPW), right ventricular end-systolic volume (RVESV), and cardiac function indicators were compared among the 3 groups. The correlations between the expression of natriuretic peptide receptor A and NT-proBNP, ventricular remodeling, TGF-β1, myocardial fibrosis, cardiac function, and lipid indexes in 120 patients with diabetic cardiomyopathy were analyzed by Pearson correlation analysis. The statistical methods used were F test and χ2 test. Results The levels of natriuretic peptide receptor A, NT-proBNP, and TGF-β1 in the diabetic cardiomyopathy group were higher than those in the control group and the diabetic group [0.72±0.21 vs. 0.32±0.17 and 0.47±0.21, (1 586.23±300.28) ng/L vs. (1 041.06±284.03) ng/L and (1 313.65±292.16) ng/L, (235.44±30.19) ng/L vs. (221.21±31.06) ng/L and (228.33±30.63) ng/L]; the levels of sST2, TIMP-1, TC, TG, LDL-C, LVRI, LVPW, RVESV, and LVEDD were higher than those in the control group and the diabetic group, while the levels of MMP-2, HDL-C, LVEF, E/A, and SV were lower than those in the control group and the diabetic group, with statistically significant differences (all P<0.05); there were statistically significant differences in the above indexes between the control group and the diabetic group (all P<0.05). Pearson correlation analysis showed that natriuretic peptide receptor A was positively correlated with the levels of NT-proBNP, TGF-β1, sST2, TIMP-1, TC, TG, LDL-C, LVRI, LVPW, RVESV, and LVEDD in patients with diabetic cardiomyopathy (r=0.432, 0.415, 0.431, 0.418, 0.441, 0.513, 0.475, 0.526, 0.548, 0.519, and 0.356, all P<0.05), was negatively correlated with the levels of MMP-2, HDL-C, LVEF, E/A, and SV (r=-0.349, -0.482, -0.342, -0.294, and -0.351, all P<0.05). Conclusion The lower the expression of natriuretic peptide receptor A in patients with diabetic cardiomyopathy, the higher the levels of NT-proBNP and TGF-β1, and the better the cardiac function.